On July 15, Quantinuum fell 5.61% in regular trading, trading at $62.679/share, with turnover of $31.15 million.

On the news front, since multiple top-tier Wall Street investment banks collectively initiated coverage on June 29, the stock has experienced sustained wide-range volatility due to valuation divergence. Target prices range from Rosenblatt's $155 high to Morgan Stanley's $78 with an Equalweight rating — a near-double gap reflecting fundamental disagreement over quantum computing commercialization prospects. JPMorgan initiated at Overweight with a $97 target, while BofA Securities, Needham, UBS, Jefferies, Mizuho, and Cantor Fitzgerald all initiated with Buy or Outperform ratings at targets between $90 and $100.

Adding to selling pressure, the company has been public for just over one month, with Q1 revenue plunging 73% year-over-year and net losses widening to $136.5 million, underscoring near-term fundamental headwinds for this quantum computing platform company.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)